The morning mapping session was worse than the first.
Elias lay strapped to the reclining chair in Wing C, electrode cap pressing cold against his skull, while the technician—the same gaunt woman with hollow cheeks—adjusted current levels on her monitoring console. The server racks hummed their hungry song, and somewhere in the circuitry, OmniCorp's algorithms were dissecting his memories like specimens pinned to a board.
"Try to relax," the technician said, her voice flat and mechanical. "Muscle tension interferes with the readings."
Relax. While electricity coursed through his cerebral cortex. While machines catalogued his fears, his desires, his private shames. While somewhere in the cloud, seventeen million stolen medical records were being cross-referenced with the neural architecture of involuntary patients. Relax.
Elias closed his eyes and thought of the journal hidden beneath his mattress. Samuel Brandt's handwriting, cramped and urgent, documenting the transformation of therapeutic technology into weapon. He thought of the keycard—CHMR-7-ALPHA—and what it might unlock. He thought of Lydia Markov's gray eyes and Dr. Helena Brandt's voice in the darkness, offering help that might be genuine or might be the next layer of the experiment.
The current increased, and Elias felt something inside his mind shift—a memory dislodged, a connection severed. He gasped, his hands clenching against the restraints.
"Good," the technician murmured, making a note. "The algorithm is detecting increased access to long-term memory engrams. We're getting excellent data today."
Excellent data. The words echoed in Elias's skull like a curse. His memories were being extracted and packaged, transformed into proprietary information that OmniCorp would sell to advertisers, political campaigns, anyone with enough kroner to purchase the architecture of human consciousness. And he was powerless to stop it—strapped to a chair, electrodes drilling into his brain, while a woman who had surrendered her humanity made notes about the quality of the harvest.
The session lasted fifty-three minutes. When it ended, Elias was too weak to walk. Slade and another orderly had to half-carry him back to his room, his legs dragging, his vision swimming with fragments of memories that no longer quite connected. He lay on his bed for hours afterward, trying to remember his mother's face and finding only static.
By late afternoon, some of the fog had cleared. Elias sat in his usual chair in the common area, beside Markov, while the other patients shuffled their medicated circles around them. The dead television flickered silently on the wall, tuned to a news channel that showed Prime Minister Adrian Kos shaking hands with OmniCorp's CEO at a technology summit in Nordhaven.
"They're announcing a new public-private partnership," Markov said, her voice barely audible. "Neuralytics for national security. OmniCorp is going to screen government employees for 'cognitive vulnerabilities.' That's what they're calling it."
Elias watched the silent footage—the handshake, the smiling faces, the corporate logos displayed prominently behind the podium. "How many government employees are we talking about?"
"Every federal worker with security clearance. Approximately four hundred thousand people. The screening program begins next quarter." Markov's fingers traced patterns on her chair arm—the same patterns she always traced, but Elias had begun to recognize them now. Not random movements. Code. A mnemonic system she had developed to preserve information through the mapping sessions.
"That's not screening," Elias said. "That's harvesting. Four hundred thousand federal employees, plus their families, plus anyone connected to them through the Neuralytics data-sharing agreements. OmniCorp isn't building a security program. They're building a surveillance infrastructure that covers the entire government."
"Exactly. And they're using us—the patients at Cresthaven—as the beta testers. Every mapping session refines the algorithm. Every extracted memory improves the pattern recognition. By the time they start screening government employees, they'll have perfected the technology on involuntary subjects." Markov paused, her gray eyes meeting his for just a moment. "How bad was the session this morning?"
"Bad. I'm losing things. Small things, mostly—names, dates, the color of my first apartment. But the gaps are getting larger."
"Your first apartment. Do you remember the address?"
Elias searched his memory. The building was there—a narrow walk-up in Northbridge's old district, with creaking stairs and a radiator that clanked all winter. But the street name, the number, the details that had once been vivid—they were fading, dissolving like morning frost under harsh light.
"No," he said quietly. "I can't remember the address."
Markov nodded, unsurprised. "After nineteen months, I've lost most of my childhood. My first byline. The sound of my father's voice. But I've learned to protect the important things—the information that matters, the memories that define who I am. I store them in patterns, in repeated movements, in songs I hum under my breath during the sessions. The algorithm targets narrative memory, but it doesn't recognize procedural memory the same way. If you encode what you need to keep in a rhythm, a sequence, a physical habit—sometimes you can save it."
"That's why you trace patterns on the chair."
"That's why I trace patterns on everything. Every wall, every table, every surface in this facility that I can touch. I've been writing the same information into the world for nineteen months, hoping someone would learn to read it." She looked at him, her expression unreadable. "You're the first person who has."
Elias absorbed this—the magnitude of what Markov had accomplished, the sheer stubborn will required to maintain coherence through nineteen months of systematic neural destruction. He thought of Samuel Brandt's journal, still hidden beneath his mattress, and the keycard, still tucked into his waistband. He thought of the partial download somewhere in OmniCorp's cloud, waiting to be retrieved.
"Brandt's husband," he said. "Samuel. He was working on something before he died—something that terrified him enough to try to go public. Did you ever meet him?"
Markov shook her head. "He died six months before I was committed. But I heard about him from other patients. The ones who've been here the longest—they remember Dr. Brandt. They say he was different from Crane. That he actually tried to help people. That he asked too many questions about the mapping sessions, about where the data was going, about why patients kept deteriorating instead of improving."
"Someone betrayed him. Someone on his research team—someone he considered a friend—reported him to OmniCorp security. Brandt told me that much. But she doesn't know who."
"Does it matter? Whoever it was, they're probably still here. Still watching. Still reporting."
"It matters because if we don't identify them, they'll betray us too. Everything we're planning—the server access, the data extraction, the exposure—it all falls apart if there's a mole feeding information to Crane."
Markov was silent for a long moment. Then she said, "There's a patient on the third floor. Room 314. His name is Anton Varga. He was a research assistant at OmniCorp's Valdorian campus before he was committed—one of the first, eighteen months before me. He worked directly under Samuel Brandt."
"Why is he still here?"
"Because he knows something. Something OmniCorp is afraid of. They've kept him sedated almost continuously for two years—Thorazine, Haloperidol, enough benzodiazepines to keep an elephant docile. But sometimes, between doses, he talks. He says things that don't make sense. Fragments. Names. Dates." Markov's eyes met his again. "He might know who betrayed Samuel Brandt. If you can reach him. If you can find a way to talk to him during one of his lucid windows."
"The third floor. That's the high-security ward. Maximum sedation, maximum restraint, minimum contact with other patients."
"Yes. Getting there will be... difficult."
Elias thought of the service corridors Brandt had shown him, the hidden passages that Samuel had mapped before his death. "There might be a way. But I'll need Brandt's help. And I'll need you to cover for me—create a distraction, keep the orderlies occupied."
"I can do that. But be careful, Voss. The third floor isn't like the rest of Cresthaven. The patients up there are the ones OmniCorp considers permanently dangerous. They don't get visitors. They don't get recreation time. They barely get acknowledgment that they're still human."
That night, Elias waited until the facility settled into its nocturnal rhythm before retrieving Samuel Brandt's journal from beneath his mattress. He had read fragments of it over the past two days, deciphering the cramped handwriting in the dim light that filtered under his door. But he hadn't yet read it cover to cover, systematically, the way a data analyst approached a complex dataset.
Now, with the mapping session's fog still clinging to the edges of his consciousness, he began at the beginning.
September 14. Initial observations confirm what I suspected: the Chimera protocol is being deployed on human subjects without informed consent. Patient 4402, admitted under Section 5150, underwent three mapping sessions this week. Her cognitive baseline has degraded 17% in seven days. When I raised concerns with Dr. Crane, he assured me the decline was consistent with her underlying pathology. But 4402's admitting diagnosis was anxiety disorder. There is no clinical literature connecting anxiety to the specific memory fragmentation I observed.
September 21. I have identified seven additional patients exhibiting similar cognitive degradation patterns. All were involuntarily committed. All had some connection—however tangential—to OmniCorp or its subsidiaries. Former employees. Journalists. Whistleblowers. The pattern is too consistent to be coincidental.
September 30. Confronted Crane directly today. Told him I would file a formal complaint with the Valdorian Medical Ethics Board if the mapping sessions weren't suspended pending independent review. Crane's response was... unsettling. He smiled. He told me I was being naive, that the work we were doing at Cresthaven was too important to be derailed by procedural concerns. When I pressed him, he mentioned Helena's name. Not as a threat, exactly—more as a reminder. A reminder that I have things to lose.
October 7. I have begun documenting everything. Patient files. Mapping protocols. Internal communications between Cresthaven and OmniCorp's Biosciences Division. If something happens to me, this journal will serve as a record. I've hidden a duplicate in a location only Helena knows about. The keycard—the one that accesses the Chimera server—I've given to her as well. She doesn't know what it opens, but she knows it's important.
October 15. Someone has been accessing my office after hours. Small things out of place—a file moved, a drawer left slightly open. I suspect one of the research assistants, but I don't know which one. There are three on my team: Anton Varga, a brilliant but nervous young man who seems genuinely troubled by what we're witnessing; Mira Chen, a neurologist who transferred from OmniCorp's Nordhaven campus six months ago; and David Kosloff, a data analyst who previously worked in OmniCorp's legal division. Any of them could be reporting to Crane. Perhaps all of them.
Elias paused, his finger resting on the names. Anton Varga—the patient on the third floor, the research assistant who had worked directly under Samuel Brandt. According to Markov, Varga had been committed eighteen months after the events described in the journal. What had happened in those eighteen months? What had Varga witnessed that made him dangerous enough to be sedated into near-oblivion for two years?
He continued reading.
*October 22. I have identified the primary server where the Chimera project data is stored. It's located in a restricted-access node on OmniCorp's internal network—not at Cresthaven, but at the Valdorian research campus downtown. The neural mapping data from Cresthaven patients is transmitted there nightly, where it's integrated with other data streams: medical records, financial histories, social media activity, biometric surveillance feeds. OmniCorp isn't just mapping individual brains. They're building a comprehensive model of human behavior—a predictive algorithm that can anticipate decisions, manipulate preferences, identify vulnerabilities. The commercial applications are staggering. The political applications are terrifying.*
October 28. I've made a decision. I'm going to go public. I've contacted a journalist—Lydia Markov, an investigative reporter with the Valdorian Press. She's agreed to meet with me next week. I've prepared a package of documents: patient data, mapping protocols, internal communications. Enough to expose what's happening here. I know the risks. Crane has made it clear that people who threaten OmniCorp's interests have a tendency to... disappear. But I can't live with myself if I stay silent.
Elias felt a chill run through him. Samuel Brandt had contacted Lydia Markov—the same Lydia Markov who had been committed to Cresthaven two years later. The connection between them wasn't coincidental. Markov had been investigating OmniCorp because Samuel Brandt had given her the story.
He turned the page. The next entry was dated October 29—the day before Samuel Brandt died.
Someone knows. I came home tonight and found the lock on my study door broken. Nothing was taken—not the computer, not the files, not any of the obvious targets. But the journal was moved. They know I've been documenting everything. They know I've been planning to go public. I called Markov to warn her, but she didn't answer. I left a message. I hope she gets it in time.
If you're reading this, Helena, I'm sorry. I should have been more careful. I should have protected you better. The duplicate files are where I told you—the safety deposit box at the Northbridge Central Bank, number 7842. The key is hidden in the medication cart, third drawer, behind the Diazepam. I love you. I'm sorry.
That was the last entry. The journal ended there, on October 29, the day before Samuel Brandt was found dead in his home, an injection site on the back of his neck, his wrists marked with restraints.
Elias closed the journal and stared at the ceiling. The pieces were falling into place, forming a picture more horrifying than he had imagined. Samuel Brandt had been murdered because he was about to expose Project Chimera. Lydia Markov had been committed because she had picked up the story where Brandt left off. And Elias himself—the lead plaintiff in the class action, the former data architect who knew too much—had been committed because OmniCorp had built an entire infrastructure for disposing of inconvenient people.
But there was one piece that didn't fit. One name that appeared in the journal and then vanished. The traitor—the person on Brandt's research team who had been accessing his office, reporting his activities to Crane. Varga, Chen, or Kosloff. One of them had sold Samuel Brandt to OmniCorp. And one of them might still be here, still watching, still waiting for the next person to betray.
The following afternoon, during the medication line, Elias managed to catch Dr. Brandt alone for thirty seconds—in the corridor near the supply closet, where the surveillance cameras had a blind spot.
"I need to get to the third floor," he said. "There's a patient there—Anton Varga. He worked with your husband."
Brandt's face went pale. "Anton Varga has been in a chemically induced stupor for two years. He's not capable of—"
"He has lucid windows. Markov confirmed it. He knows something about who betrayed Samuel. If I can reach him, I might be able to find out who the mole is."
"Even if that's true, the third floor is restricted. Keycard access only, biometric verification, camera coverage on every corridor. There's no way—"
"Samuel mapped the service corridors. You showed me yourself. The passages run through the entire facility, including the third floor. I need you to get me the access codes for the third-floor junction. And I need you to tell me everything you know about Mira Chen and David Kosloff."
Brandt stared at him, and for a moment, Elias saw something flicker in her eyes—fear, or grief, or perhaps both. "Mira Chen transferred to OmniCorp's overseas division two years ago. She's in the Krovian Republic now, running a research lab that specializes in neural marketing applications. David Kosloff..." She hesitated.
"What about Kosloff?"
"David Kosloff is Dr. Crane's nephew. He was embedded in Samuel's team specifically to monitor him. After Samuel died, Kosloff was promoted. He's now the director of OmniCorp's Biosciences legal division."
Elias felt the final piece click into place. "Kosloff. He was the one who betrayed your husband."
"I've suspected it for two years, but I've never been able to prove it. The security footage from Samuel's final week was erased. The access logs from his office were purged. Kosloff covered his tracks perfectly, and Crane protected him."
"Then why is Varga still here? If Kosloff was the traitor, why keep Varga sedated on the third floor?"
Brandt's expression darkened. "Because Varga witnessed something. Something beyond the data harvesting, beyond the cognitive manipulation. When he was committed—eighteen months after Samuel's death—his intake forms listed the reason as 'paranoid schizophrenia with violent tendencies.' But the real reason, I believe, is that he saw what happened to the patients who were considered permanently non-cooperative. The ones who couldn't be 'cured' or 'released.'"
"What happened to them?"
"I don't know. That's the worst part. Patients have disappeared from Cresthaven over the years—transferred to other facilities, according to the official records. But some of those facilities don't exist. I've checked. The addresses lead to empty lots, abandoned buildings, addresses that were never occupied. And the patients who were transferred there—none of them have ever been heard from again."
Elias thought of the Neuro-Mapping Wing, of the electrodes and the servers and the systematic extraction of human consciousness. He thought of how far a corporation might go to protect its secrets, to perfect its technology, to eliminate the witnesses who threatened its interests. And he realized that the question wasn't whether OmniCorp was capable of murder.
The question was how many people they had already killed.
No comments yet. Be the first to comment!